Global Transcriptomics Market Competitive Landscape & Forecast to 2019

Press Release   •   Sep 30, 2014 09:12 EDT

The global transcriptomics market will reach $3,773.0 million by 2019, growing at a CAGR of 13.7% during the forecast period (2014–2019). RNR presents analysis and discussion about transcriptomics market, its forecasts and more is now available at ReportsnReports.com.

The global transcriptomics market is expected to grow at a CAGR of 13.7% during the forecast period of 2014 to 2019 and is estimated to be worth $3,773.0 million by 2019. The transcriptomics market has blatantly grown in the past few years primarily due to the increasing technological advancements in the field of sequencing technologies in transcriptomics research. Similarly, the increasing government and private funding for research coupled with research and development investments by the biotechnology companies are expected to drive the transcriptomics market. The increasing adoption of transcriptomics in the field of biomarker discovery opens new growth avenues with the rising preference of personalized medicine across the globe. However, the higher investment costs that restrict the adoption of transcriptomics products and dearth of skilled professionals are the factors hampering the growth of this market to a certain extent.

The transcriptomics market report covers the transcriptomic technologies, applications and end-users. The technologies market in this report is segmented as microarray, PCR, sequencing technologies which include Sanger sequencing and NGS, and RNAi gene silencing technology. Each of these technologies market is further sub-segmented into reagents, instruments and software. The applications of transcriptomics covered under the scope of this report are clinical diagnostics, drug discovery, and toxicogenomics. The end-users of transcriptomics are pharmaceutical and biotechnology companies, academic research and government institutes, and hospitals and diagnostic centers. This report also discusses the key market drivers, restraints, opportunities, challenges, and trends in the global transcriptomics market and its submarkets.

Complete report available at http://www.reportsnreports.com/reports/298661-rna-analysis-transcriptomics-market-by-technology-microarray-pcr-ngs-rnai-by-application-clinical-diagnostics-drug-discovery-toxicogenomics-by-end-user-academic-research-pharmaceutical-and-biotech-companies-global-forecast-to-2019.html .

By 2019, North America will continue to dominate and drive the transcriptomics market, primarily due to the rising preference for personalized medicines which use biomarkers developed with the transcriptomic technologies. On the other hand, the market in Asia-Pacific region is expected to grow at a highest CAGR during the forecast period mainly due to the growing pharmaceutical and biotech industries in China and India. The reduction in funding for research and development coupled with decrease in the investment in research by the pharmaceutical and biotechnology companies in the European region as a means of cost containment is expected to hamper the growth of transcriptomics market in Europe.

The prominent players in the global trancriptomics market are Affymetrix Inc. (U.S.), Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), GE Healthcare (U.S.), Illumina Inc. (U.S.), Qiagen N.V. (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Sigma Aldrich (U.S.), Fluidigm Corporation (U.S.), and Thermofisher Scientific Inc. (U.S.).

Inquire for discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=298661 . (Original Price US $4650 for single user)

Table of Contents for “RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019” research report includes:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Trends

7 Transcriptomics Technologies Market, By Type

8 Global Transcriptomics Market, By Application

9 Global Transcriptomics Market, By End User

10 Global Transcriptomics Market, By Geography

11 Company Profiles

12 Competitive Landscape

13 Appendix

List of Figures

Figure 1 Research Methodology

Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region

Figure 3 Bottom-Up Approach

Figure 4 Top-Down Approach

Figure 5 Data Triangulation Methodology

Figure 6 Technological Advancements to Play Vital Role in the Omics Industry

Figure 7 Market Segmentation: By Type

Figure 8 Global Market: By Application

Figure 9 Global Market, By End User

Figure 10 Key Market Dynamics

Figure 11 Affymetrix Inc. : Company Snapshot

Figure 12 Agilent Technologies Inc. : Company Snapshot

Figure 13 Bio-Rad Laboratories Inc.: Company Snapshot

Figure 14 General Electric Co. : Company Snapshot

Figure 15 Illumina Inc. : Company Snapshot

Figure 16 Qiagen N.V.: Company Snapshot

Figure 17 F. Hoffmann-La Roche Ltd : Company Snapshot

Figure 18 Sigma Aldrich: Company Snapshot

Figure 19 Thermofisher Scientific Inc. : Company Snapshot

Figure 20 Fluidigm Corporation: Company Snapshot

Purchase a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=298661 . (This is a premium research report priced at US$ 4650 for single user PDF license).

About Us:

ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets. This comprehensive collection of market research reports include market share analysis, industry analysis, information on products, countries, market size, trends, business research details and much more. Our research specialists & industry experts, through our market research offerings, ensure we deliver on all your business & industry research requirements - first time and every time!